New PET/MRI scan to check brain tumors after treatment
Part of Brain & nervous system, Cancer clinical trials.
This study uses a special PET/MRI scan with an amino acid tracer to better see if brain tumors (either starting in the brain or spreading from elsewhere) have come back after treatment. The scan may help doctors tell the difference between tumor growth and treatment-related changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a brain tumor (either primary or secondary).
- You have had treatment, and a recent MRI shows a new or suspicious spot that is bigger than 1 centimeter.
- You are able to lie still for a PET/MRI scan (no metal implants, not pregnant, no severe allergies to contrast dye).
- You are willing to sign a consent form and allow researchers to use your medical records for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
This study checks whether a special scan called PET-MRI can better tell if a child’s brain tumor has come back after treatment. It may help doctors decide faster and more accurately when changes seen on regular MRI are true tumor recurrence.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This study looks at how well a specific PET scan (using a tracer called [18F]FET) can help doctors diagnose brain tumors, check how well treatment is working, or spot tumors that come back. Researchers will analyze images you may have already had or will have as part of your regular care.
This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
Hear when a new Primary and Secondary Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.